You've Done Everything Right and Still Can't Conceive. Here's the Biological Reason.

MTHFR is one of the most important genes for pregnancy. It encodes an enzyme that converts folate into its active form, methylfolate, which your cells use to build DNA and RNA. Every time a cell divides, especially during early embryo development, your body needs massive amounts of methylated compounds. MTHFR is the gatekeeper that makes this possible.

The most common variant is C677T. Roughly 40% of people with European ancestry carry at least one copy. If you have one copy, your enzyme works at about 65% efficiency. If you have two copies, it’s more like 30% efficiency. With MTHFR C677T, your embryos are trying to develop with a severely constrained supply of methylated nutrients. Folate supplementation helps but doesn’t fully compensate. Your homocysteine levels also rise, and elevated homocysteine is associated with miscarriage and poor egg quality.

You might notice you miscarry early, or struggle to conceive at all. Your eggs might be poor quality on ultrasound. Your embryos might fail to develop normally. You might have a history of pregnancy loss. Standard prenatal vitamins won’t fix this because they contain folic acid, which your MTHFR variant can’t efficiently convert. You need the methylated form.

Your pituitary gland produces FSH (follicle stimulating hormone) to tell your ovaries to mature eggs. Your ovaries have FSH receptors on their surface that bind to FSH and trigger egg development. FSHR is the gene that codes for this receptor. If your FSHR receptor is less sensitive, your ovaries require much more FSH to respond, or they respond sluggishly no matter how much you give them.

The N680S variant affects how well your ovarian cells respond to FSH signaling. Roughly 10-15% of women carry the S/S genotype, which is associated with poor ovarian response. Women with the S/S genotype need higher doses of FSH during IVF stimulation and produce fewer eggs, even with aggressive protocols. This is the genetic basis of poor ovarian response. Your ovaries aren’t broken; they’re just less sensitive to the hormone trying to wake them up.

In an IVF cycle, you’ll notice you need higher gonadotropin doses than other women your age. Your follicle count will be lower. You might be told you have diminished ovarian reserve when your FSH levels are actually normal. You’ll cycle after cycle without producing enough eggs. Your doctor might suggest you’re getting too old, but the real problem is your ovarian cells can’t hear the FSH signal clearly.

Your uterus doesn’t just hold a pregnancy. The lining (endometrium) has to actively accept and integrate an embryo. This acceptance requires estrogen. Your endometrial cells have estrogen receptors on their surface, coded by the ESR1 gene. These receptors bind to estrogen and activate a cascade of genes that prepare your uterus for implantation. If your estrogen receptors aren’t functioning optimally, your endometrium can’t prepare properly.

The PvuII and XbaI variants affect how well estrogen receptors function. Roughly 40% of women carry variants associated with reduced estrogen receptor sensitivity. Women with ESR1 variants have endometrial tissue that doesn’t respond as well to estrogen signaling, making implantation harder and pregnancy less likely to stick. This is why some women have perfect embryos, perfect uterine anatomy, and still experience recurrent implantation failure. The problem is at the cellular level: their endometrium isn’t receiving the estrogen signal clearly enough to prepare for pregnancy.

You might have a history of failed embryo transfers even with genetically normal embryos. You might get pregnant easily but miscarry in the first trimester. Your endometrial thickness might look okay on ultrasound but implantation still fails. Your doctor might suggest surrogacy when the real problem is your endometrium needs specific estrogen support to prepare properly.

CFTR codes for the cystic fibrosis transmembrane conductance regulator. Most people know it from cystic fibrosis, a severe lung disease. But CFTR is also critical for reproductive tract development. During fetal development, CFTR helps form the vas deferens (the tubes that carry sperm). Without proper CFTR function, these tubes fail to develop, a condition called congenital bilateral absence of the vas deferens (CBAVD).

Carrier variants of CFTR are surprisingly common, roughly 1 in 25 people of European ancestry carry at least one variant. Most carriers have no respiratory symptoms (cystic fibrosis requires two mutated copies). But male carriers can have CBAVD and present with azoospermia (zero sperm) or obstructive azoospermia. A man with a CFTR carrier variant can have completely normal sperm production but an obstructed reproductive tract, making ejaculated sperm retrieval impossible. Standard semen analysis shows azoospermia, but the underlying cause is anatomical, not testicular.

You might be told you have azoospermia and fertility is impossible without TESE (testicular sperm extraction). Your doctor might not realize you’re a CFTR carrier. You’d pursue expensive surgical sperm retrieval when the real issue is a structural blockage. CFTR carrier testing changes the entire diagnostic picture.

The DAZL gene (Deleted in Azoospermia Like) sits on the Y chromosome in a region called the AZF (azoospermia factor). This gene is absolutely required for spermatogenesis, the process of making sperm from stem cells. Your body continuously regenerates sperm from germ cells, a process that takes about 74 days. DAZL orchestrates the genes that tell these cells to divide, differentiate, and mature into functional sperm.

Deletions in the AZF region, particularly AZFa, AZFb, and AZFc deletions, are found in roughly 1 in 2,000 to 3,000 men with infertility. Men with DAZL deletions or AZF deletions produce no sperm (azoospermia) or extremely few sperm (severe oligospermia). This is not a functional problem; this is a genetic missing piece. No amount of lifestyle intervention, hormone therapy, or nutritional support will restore spermatogenesis if the genetic blueprint is deleted.

You might present with azoospermia on your semen analysis. Your testosterone is normal, your doctor says everything looks fine hormonally, but you have no sperm. You’ve been told infertility is permanent. The real cause is a Y chromosome deletion that standard hormone testing never identifies. DAZL deletion testing clarifies whether your azoospermia is salvageable (with sperm retrieval) or whether sperm donation is your path forward.

The androgen receptor (AR) is how your body’s cells listen to testosterone. The AR gene codes for this receptor protein. When testosterone binds to the androgen receptor, it triggers the cascade of genes needed for spermatogenesis, male sexual development, and male secondary characteristics. If your androgen receptor is less sensitive (or if you have fewer receptors), testosterone can be present in normal amounts but your body won’t respond as strongly.

The AR gene contains a CAG repeat segment that varies in length between individuals. Longer CAG repeats (over 26 repeats) are associated with lower androgen receptor sensitivity. This is common in the population and exists on a spectrum. Men with longer CAG repeats have lower androgen receptor sensitivity, which impairs spermatogenesis and can result in low sperm count or poor sperm motility even with normal testosterone levels. Testosterone replacement therapy won’t help because the problem isn’t testosterone availability; it’s receptor responsiveness.

You might have oligospermia (low sperm count) with normal or even elevated testosterone levels. Your doctor might suggest testosterone replacement, which would actually make your infertility worse by suppressing the pituitary’s natural testosterone production. You might have poor sperm motility that doesn’t respond to standard fertility interventions. AR sensitivity testing reveals that your spermatogenesis is limited not by hormone levels but by how well your cells can respond to those hormones.